Bio-Reference Laboratories Inc $27.39

up +0.16


16/4/2014 05:20 PM  |  NASDAQ : BRLI  
Industries : Health Services / Medical Laboratories & Research
Get Trend Analysis Icon Get BRLI Trend Analysis - it has underperformed the S&P 500 by 4%

Partner Headlines

  1. Medical Diagnostic Labs Facing Medicare Headwinds

    GuruFocus
  2. Myriad Stock Tumbles After Court Allows Rival To Sell

    IBD
  3. Earnings Scheduled For March 4, 2014

    Benzinga
  4. Historical Short Interest Of Stocks - New Feature Announcement

    GuruFocus
  5. Myriad Price Cut Reflects Changing Gene-Test Industry

    IBD
  6. Myriad Hit By Downgrades After Reimbursement Cut

    IBD
  7. Earnings Scheduled For December 19, 2013

    Benzinga
  8. Stocks With The Highest Short Interest - New Feature Announcement

    GuruFocus
  9. UPDATE: Bank of America Lowers PT on Bio-Reference Laboratories Following ...

    Benzinga
  10. Myriad Genetics Sued On Gene Patents; Stock Falls

    IBD
  11. Alere Financial Says Bio-Reference Laboratories' Reimbursement Volatility ...

    Benzinga
  12. Bio-Reference cuts outlook

    IBD
  13. Stocks Up Slightly In Late Trade; Pegasystems Climbs

    IBD
  14. Bio-Reference Labs Slashes Guidance; Stock Plunges

    IBD
  15. Morning Market Losers

    Benzinga
  16. Earnings Scheduled For August 29, 2013

    Benzinga
  17. BioReference Reports Purchase of Edge BioSystems' Service Business, No ...

    Benzinga
  18. Myriad Genetics Falls On Downgrade, Despite Q4 Beat

    IBD
  19. Top 4 Small-Cap Stocks In The Medical Laboratories & Research Industry ...

    Benzinga
  20. Bio-Reference Labs Offers Extremely Stable Earnings

    IBD
  21. Quest Diagnostics Overhaul Continues With Unit Sale

    IBD
  22. Quest Diagnostics Overhaul Continues With Unit Sale

    IBD
  23. BioReference Laboratories Inc. Reports Operating Results (10-K)

    GuruFocus
  24. Bio-Reference Labs, Inc. (BRLI) Sr. VP, Sec'y, Treasurer, CFO Sam Singer ...

    GuruFocus
  25. Buffett-Munger Model Portfolio Posts Fourth Solid Year, Hits Refresh for ...

    GuruFocus
  26. Bio-Reference meets on Sandy

    IBD
  27. Stocks Mixed As Rally Fades; Lululemon Bounces Back

    IBD
  28. Bio-Reference Earnings Meet Views Despite Hurricane

    IBD
  29. Earnings Scheduled For December 6, 2012

    Benzinga
  30. Buffett-Munger Strategy: What Worked? What Didn't

    GuruFocus
  31. Many Stocks Dip In Weak Trade Amid Market Correction

    IBD
  32. Bio-Reference Laboratories Inc Reports Operating Results (10-Q)

    GuruFocus
  33. Buffett-Munger Model Portfolio Gained 16.1% Year-to-Date

    GuruFocus
  34. Stocks Back Off, So Does Volume

    IBD
  35. Health Care Sector Wrap

    FoxBusiness
  36. Stocks Trim Losses After Sliding Further

    IBD
  37. Bio-Reference Shares Fall On Q3 Revenue Shortfall

    IBD
  38. Stocks Trim Losses After Sliding Further

    IBD
  39. First Solar, Sears Holdings Among Stocks Down on Above-average Volume Thursday

    FoxBusiness
  40. US Stock Futures Down; Jobless Claims Data In Focus

    Benzinga
  41. Earnings Scheduled For August 30, 2012

    Benzinga
  42. Stocks To Watch For August 30, 2012

    Benzinga
  43. Health Care Sector Wrap

    FoxBusiness
  44. Health Care Sector Wrap

    FoxBusiness
  45. Buffett-Munger Model Portfolio Continues Its Outperformance

    GuruFocus
  46. Several Medical Stocks Climb From Breakouts

    IBD
  47. Stocks Sink In Late Trading; Mellanox Reverses Lower

    IBD
  48. Stocks Near Intraday Highs; Under Armour In Buy Area

    IBD
  49. Bio-Reference Laboratories up 6% on BofA Upgrade

    Benzinga
  50. Stock Gains Hold In Early Afternoon; Questcor Climbs

    IBD
Trading Center